Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

37 trials with published results (28%)

Research Maturity

73 completed trials (55% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

5.3%

7 terminated out of 133 trials

Success Rate

91.3%

+4.7% vs benchmark

Late-Stage Pipeline

1%

1 trials in Phase 3/4

Results Transparency

51%

37 of 73 completed with results

Key Signals

37 with results91% success

Data Visualizations

Phase Distribution

111Total
Not Applicable (99)
Early P 1 (1)
P 1 (7)
P 2 (3)
P 3 (1)

Trial Status

Completed73
Recruiting21
Unknown14
Terminated7
Enrolling By Invitation6
Active Not Recruiting5

Trial Success Rate

91.3%

Benchmark: 86.5%

Based on 73 completed trials

Clinical Trials (133)

Showing 20 of 20 trials
NCT05973669Not ApplicableCompletedPrimary

MED-EL Remote Care Multi-Center Feasibility Study

NCT05215197Not ApplicableRecruitingPrimary

Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation

NCT06424262Not ApplicableCompleted

Performance and Hearing-related Outcomes in Adults Implanted With the CI622D Dexamethasone-eluting Cochlear Implant Compared to Those Implanted With a Standard Cochlear Implant (CI622)

NCT06370351Phase 1Active Not Recruiting

A Phase I/II Clinical Trial With SENS-501 in Children Suffering From Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations

NCT03686046CompletedPrimary

Evaluation of an Open-source Speech-processing Platform

NCT07667140Not ApplicableCompletedPrimary

Standard Post Market Clinical Follow-up (PMCF) Study WSA 2026

NCT06293482Not ApplicableActive Not RecruitingPrimary

Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population

NCT06642935Not ApplicableActive Not Recruiting

A Study to Explore Improved Features and a Simplified Treatment Approach for a Totally Implantable Cochlear Implant (TICI) Research System in Adults With Severe Hearing Loss

NCT06437054Phase 1WithdrawnPrimary

Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss

NCT06962540Not ApplicableEnrolling By InvitationPrimary

Understanding Individual Listening Strategies

NCT04240561Not ApplicableRecruitingPrimary

Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia

NCT05808543Not ApplicableRecruitingPrimary

BEARS Training Package to Maximise Hearing Abilities in Older Children and Teenagers With Bilateral Cochlear Implants

NCT07500311Not ApplicableEnrolling By InvitationPrimary

Comparison of Performance Using MED-EL Automatic Sound Management

NCT06734039Not ApplicableEnrolling By Invitation

Impact of Anatomy-Based Cochlear Implant Programming on Early Performance

NCT06114680Not ApplicableTerminatedPrimary

Evaluation of the CochSyn Test Prototype to Measure Cochlear Synaptopathy

NCT07091071Not ApplicableCompletedPrimary

Evaluation of the CochSyn Device in Clinical Practice

NCT07028619Not ApplicableCompletedPrimary

Benefits of Bimodal Streaming With MED-EL Cochlear Implants and Starkey Hearing Aids

NCT07380269Recruiting

Cochlear Implant Recipients: Comprehensive Longitudinal Evaluation

NCT06058767Not ApplicableRecruiting

Preschool Hearing Screening

NCT05776459Phase 2Active Not RecruitingPrimary

Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)

Scroll to load more

Research Network

Activity Timeline